that, as an article, your study would need to retain a separate Results and Discussion section and include all of the Material and Methods in the main manuscript.
I look forward to seeing a revised form of your manuscript when it is ready. In the meantime, please contact me if I can be of any assistance.
REFEREE REPORTS Referee #1:
This manuscript investigates the role of the serine/threonine-protein kinase MKKK7 in the regulation of plant innate immunity. The authors identified the corresponding kinase as an interactor of flagellin-sensitive 2 (FLS2) in their co-immunoprecipitation (IP) experiments using FLS2-GFP as bait in Arabidopsis. Reciprocal YFP-labeling on MKKK7 identified FLS2 as an interacting protein only when Arabidopsis cells were stimulated with a 22-amino acid peptide from bacterial flagellin (flg22), whereas FLS2 did not co-immunoprecitate with the GFP-tagged low temperature and saltresponsive membrane protein (Lti6B-GFP). To investigate early changes in the phosphorylation status of MKKK7 upon Arabidopsis cell stimulation with flg22, they developed a selected reaction monitoring (SRM) assay and identified residues implicated in the regulation of the kinase function. Differential phosphorylation of Ser452 and Ser854, but not Ser337, was observed in response to flg22 treatment. Transfection experiments indicated that over-expression of MKKK7 can suppress flg22-triggered defense gene activation. The authors proposed that phosphorylation is required as a negative regulator of flg22-induced gene expression based on results from mutagenesis experiments where Ser452 and Ser854 residues were mutated into non-phosphorytable Ala or phosphomimetic Asp residues and the corresponding MKKK7AA or MKKK7DD genes transfected in protoplasts cells. These experiments confirmed that phosphorylation of MKKK7 at one or both residues (Ser452/Ser854) are required to suppress basal immunity, though phosphatase or kinase targeting these sites remain unknown. Overall, this study is well executed and provides novel insights into the role of MKKK7 phosphorylation in regulating Arabidopsis immunity. Publication is recommended pending changes indicated below.
kinase kinase kinase MKKK7 is a negative regulator of immunity against the bacterial pathogen Pseudomonas syringae DC3000 in Arabidopsis.
The authors screened MKKK7 as an FLS2-interacting protein and confirmed their association in plants. They identified several phosphorylated amino acid residues in MKKK7, which are functionally important and their phosphorylation was slightly increased by flg22. In an mkkk7 mutant, flg22-induced MPK6 phosphorylation and FRK1 expression (also slightly WRKY29) were enhanced. Overexpression of MKKK7 (WT) or a phosphomimic MKKK7 but not a phoshodeficient MKKK7 led to suppression of flg22-induced FRK1 (and slightly WRKY29). Although mkkk7 mutant did not show ROS phenotype, phosphomimic MKKK7 suppressed and phosphodeficient MKKK7 enhanced ROS production. These data are correlated with resistant phenotype of mkkk7 mutant against Pseudomonas syringae DC3000.
Their developed method for detection of specific phosphor-peptides is excellent and influential to broad community.
I agree to their claim that MKKK7 is a negative regulator of immunity against the bacterial pathogen, but the mode of action is not addressed here and so speculative. Although MKKK7 associates with FLS2, there is no evidence for its relevance to downstream events such as ROS production, MPK6 phosphorylation and FRK1 induction. Also, effects of MKKK7 on ROS, MPK6 phosphorylation and FRK1 induction and resistant phenotype of mkkk7 mutant are correlation, but causality is not addressed.
In summary, although they present a high quality method for phosphor-peptide detection, a mechanism of MKKK7 function is not addressed in this manuscript. Therefore, this reviewer does not think that this manuscript significantly advances our knowledge. In addition, I do have several major concerns for their experimental designs and presentations.
(Major comments) 1. It is interesting that they found that MPK6 Y222 can be phosphorylated without T220 phosphorylation. This is worth discussing in relation to MAPKs in other kingdoms. Does the antibody used in immunoblotting recognize only MPK6 phosphorylated at both T220/Y222 or is either phosphorylation enough? Can MPK6 T220 be also phosphorylated without Y222? This should be also tested. In mkkk7 mutant, levels of only T220 and only Y222 phospho peptide are different from WT? Since MPK3 and MPK6 are considered functionally redundant in part (in fact, in Frei dit Frey et al 2014 Genome Biol, none of single mutation in MPK3, MPK4 and MPK6 led to complete loss of any gene induction including FRK1), the authors should also analyze MPK3 phosphorylation status in mkkk7 mutant. The effect of MKKK7 on MPK6 phosphorylation is small yet on FRK1 expression and resistant phenotype are large. Therefore, MKKK7 may affect both MPK3 and MPK6 phospho-status through specifically either T or Y residues.
2. If the major MKKK7 function is a negative regulation of MPK6 phosphorylation in response to flg22, resulting in enhanced FRK1 induction and resistance in mkkk7 mutant, their observation becomes beyond correlation. This should be addressed by comparing WT, mkkk7, mpk6 and mkkk7 mpk6 for FRK1 induction and bacterial resistance.
3. Enhanced bacterial resistance data of mkkk7 in Fig6D and susceptible data of MKKK7ox in FigS7 are important data sets for this manuscript. It is not clear how many independent experiments were performed. These should be repeated at least three times and combine those experiments for data presentation and statistical analysis to show reproducibility and reliability. In addition, I do not think disease symptom data in 
FigS4:
The major bands in MPK6 immunoblotting seem to be non-specific bands (perhaps Rubisco large subunit) but the bands below them are MPK6. In this case, MPK6 seems to accumulate more in mkkk7 compared to WT (10 and 30 min after flg22 treatment), so more detection of MPK6 phospho-peptide in mkkk7 mutant may be due to more MPK6 protein accumulation. This must be clarified. Including mpk6 mutant in immunoblotting will answer which bands are actually MPK6 and if MPK6 protein differentially accumulates between WT and mkkk7 mutant.
(Minor comments) 1. The last sentences in Abstract and Introduction: MKKK7 acts in PAMP signaling through FLS2 interaction are overstatements since relevance of MKKK7 and FLS2 interaction to MKKK7 function is not addressed.
2. MKKK7 is also described as MAP3Ke1, so this should be introduced for the sake of readers.
3. Page 15 line 12: "Flg22-induced MPK3 and MPK6 activation is required..." MAPK activation is sufficient for induction of FRK1 but it is not known that MAPK activation is "required". Several pathways may contribute to gene induction. Shut down of FRK1 induction by effectors cannot exclude the possibility that those effectors target multiple signaling components.
4. Page6 line 10: As far as I see, reciprocal co-IPs were not performed. Also, in Methods, "Pair wise" co-IPs does not seem to be appropriate.
Referee #3:
In this manuscript the authors identify MKKK7 as a protein kinase that physically associates with the PRR FLS2, and which negatively regulates signaling from FLS2. This represents a significant advance in our understanding of the regulation of PAMP-triggered immunity in plants, and provides one of the first examples of negative regulation of FLS2 at the level of the receptor complex. It also represents one of the first examples of a well-defined function for a MEKK family MAPKKK in Arabidopsis. The data clearly show that MKKK7 negatively regulates both MAPK signaling and ROS production triggered by FLS2, consistent with it functioning near the top of the FLS2 signaling pathway. The authors do a nice job of integrating these findings with prior work on FLS2 signaling. This work will be of interest to most biologists with an interest in signal transduction, and of particular interest to those with an interest in plant immune signaling.
In general the conclusions are well-supported by the data. The only area of concern I have is with Figures 6E, 6F and 7G. These images show symptoms on Arabidopsis plants infected with Pseudomonas syringae, including transgenic plants overexpressing MKKK7. As shown in Figure  S6 , however, overexpression of MKKK7 causes similar symptoms in the absence of P. syringae. It is thus unclear from Figure 6 whether the observed symptoms are due to MKKK7 overexpression alone, or from infection with P. syringae. Figure 7G also shares this problem. This concern could be addressed by showing uninfected plants in the same figure. Also, it would be helpful if the authors could address why MKKK7 overexpression causes such severe phenotypes. The plants appear similar to CPR-type mutants, but one would expect the opposite from overexpression of a negative regulator of defense responses. Are defense genes turned on in these plants?
Other more minor suggestions for improvement: 1)Pg 1, Line 24: the word "we" should be inserted in front of "show" 2) Pg 5, Line 7: Should state in this sentence that MKKK7 belongs to the MEKK subfamily 3) Pg 11, Line 11: Data shown in Figure S5 should be moved to We would like to thank the 3 referees of our manuscript for their constructive comments and suggestions and we have carefully read and considered each comment and suggestion. Below we respond to each comment in detail and indicate which changes to the text, the figures and the datasets we have made and where we have provided additional experimental data. The comments and suggestions have been very helpful in improving our manuscript and we acknowledge the referees contribution to these improvements. Response to the referee: We thank the referee for his/her kind comments on our manuscript. In response to the first comment of the referee we reanalyzed the entire FLS2 co-immunoprecipitation (IP) data set. This experimental data set includes three biological replicate measurements for FLS2-GFP mock treated and FLS2-GFP treated with flg22 as well as three biological replicates for our negative control Lti6B-GFP. The overall outcome is as before, with FLS2-GFP interacting in all three biological replicates with MKKK7, while in the Lti6B-GFP co-IP we only identify a single MKKK7 peptide with a low mascot score in just one of three replicas (which we consider an irreproducible result). At this moment we prefer not to share the entire data set as Dr. Robatzeks group is working on other novel FLS2-interacting proteins that were identified in these co-IPs and revealing these proteins does not contribute relevant information to our story. To address the concern raised by the referee, and after consulting with the editor Dr Rembold, we now provide more data on additional proteins interacting with FLS2-GFP and Lti6B-GFP in support of this co-IP MS data set. We provide data for known FLS2-interacting proteins, such as RBOHD, BAK1, SERK4, SOBIR and BIR1. Of these, BAK1 is known to interact more strongly with FLS2 in response to flg22, which is also nicely reflected in our data set (as shown in Dataset EV1). In addition we show a set of other proteins that co-IP with FLS2 and Lti6B (non-specific interactors) as well as proteins that co-IP only with Lti6B in three biological replicates. We have updated Table I with an additional peptide and adjusted the text on page 5 lines 26 to 28 and page 6 line 1.
Detailed response to comments
With the additional data we provide, we believe we have shown that our co-IP MS data is reproducible, and replicates what has previously been published for a selected set of known FLS2-interacting proteins. We sincerely hope referee 1 concurs with us on the point that the additional data supports the identification of MKKK7 as an FLS2-associated protein.
In support of our co-IP MS data we also provide evidence in Figure 1 for co-IP of native FLS2 with immunoprecipitated MKKK7-YFP but not with Lti6B-GFP.
In Fig. 2 and text on p. 7, did the authors also attempt to monitor changes in phosphorylation on
Ser503 and Ser854 residues? They should provide a rationale for their selection. Response to referee: We thank the referee for bringing to our attention that our manuscript was not clear on this. Indeed we set out to monitor phosphorylation on all 5 residues (S337, S452, S503, S775 and S854) known to be phosphorylated in MKKK7. We set up a selective reaction monitoring (SRM) assay for all of these phosphopeptides using light ( 14 N) synthetic phosphopeptides and we were able to detect them by SRM. However when we tried to measure the heavy ( 15 N) endogenous phosphopeptides in phospho-enriched samples derived from cultured cells or seedlings, only three of these sites (S337, S452 and S584) could be detected and quantified. We have therefore adjusted the text on page 7, lines 3, 4 and 6 and page 7, line 15 and 16 to explain this data in more detail in the manuscript.
They should comment on the conservation of residues S337, S452, S503, S775 and S854.
Response to referee: We agree with the referee that conservation of residues needs to be addressed. In response to the suggestion we have made an alignment of the closest MKKK7 homologues from related Brassicaceae species (Arabidopsis thaliana, Arabidopsis lyrata, Camelina sativa and Brassica napus) as well as more distantly related species (Solanum lycopersicum, Nicotiana benthamiana and Malus domestica). This is provided as Dataset EV2. S337, S452 and S503 appear to be conserved only in Brassicaceae, and residues S775 and S854 are conserved in all analyzed MKKK7 sequences. As suggested we added a comment at the end of page 6, line 25-27 and page 7, line 1 and 2.
Changes in phosphorylation on targeted sites should be discussed since they appear strikingly different between MKKK7 and MPK6, though the actual phosphorylation stoichiometry on all sites remains unknown. Response to referee : We agree with the referee that there are striking changes in phosphorylation between MKKK7 and MPK6, but we also feel it goes beyond the current manuscript to address differences in stoichiometry. The exact regulatory mechanism of negative regulation by MKKK7 of FLS2 output (including MPK6 phosphorylation) is not addressed in this manuscript and we feel elaborated discussion of MKKK7 versus MPK6 phosphorylation is not warranted in the current manuscript.
3. In Fig. 3 and accompanying text on p. 8, in Col-0 experiments the authors should discuss why phosphorylation on sites S337, S452, and S775 do not show an increase in phosphorylation upon flg22 induction. Response to referee: The referee is correct to notice that we do not observe differences in MKKK7 phosphorylation at 10 min flg22 in the seedlings in Figure 3B . While at first glance this may be surprising, if we examine the phosphorylation on S337, S452 and S775 in Figure 2 (in cell cultures) at 10 min we also do not observe significant differences in phosphorylation as compare to 0 min for S337, S452 and S775. So both cell culture samples and seedling samples show the same trend for these phosphorylated residues.
Minor points: 1. Typos and missing words were found in several places (e.g. Abstract lines 22-25, p11 line 17 ...) , and should be revised accordingly. Response to referee: we thank the reviewer for pointing out these mistakes and have corrected these and carefully reread the entire manuscript for similar typos and omissions. Fig. 2 should be labeled.
The y-axis in
Response to referee The Y-axis in Figure 2 has now been labeled with 'ratio endogenous/synthetic' to address the referee comment.
3. In Fig.3 , intensities with error bars are shown for non-detected SRM transitions, please clarify. Response to referee: the referee correctly notices that we have labeled several bars in Figure 3B with ND. In the first case the phosphopeptide for MPK6 is not detectable above background at t=0, while strong transitions well above background are detected at 10 min flg22 treatment. We decided to integrate the same area of the chromatogram in both cases as the background will also contribute to the integrated peak area to a certain extend. For MPK6 in Figure 3B this is only a very small proportion (5-10% of the peak area), but in other cases where the detected transitions are weaker such as S337 in Figure 3B , this background contribution may be significantly more pronounced (20 to 25%). Rather than subtracting a fixed area as background, we decided to show the actual data, and indicate that we integrate background by adding ND above bars representing background. The alternative would have been to omit the integrated background area from Figure 3B , which in our opinion was not right. We did our best to explain this as best we could in the legend of Figure 3 . We have added an additional sentence to the legend of Figure 3 to clarify, page 34 lines 9 and 10.
In method section p. 22, the authors should comment on the extent of 15N incorporation in proteins, and how was this monitored.
Response to referee : We thank the referee for pointing out this omission. Metabolic labeling of cell cultures and seedlings was previously set up in the Menke group and has been described in in two papers (Benschop et al., 2007, MCP; Zhang et al., 2012, MCP) . We routinely obtain near complete labeling (over 99.5%) with 15 N. We check the isotopic peak distribution of random peptides and compare these to theoretical isotopic peak distributions for complete 15 N labeling, to verify the incorporation rate. We have modified the text on page 22 lines 20 and 21 to describe the metabolic labeling and included the references. Response to referee : We thank the reviewer for his useful comments and suggestions. Like the referee we are also intrigued by the detection of Y222 in MPK6 and we have described this before (Mithoe et al, 2012 JPR). While we could confidently measure phosphorylation of Y222 alone and T220/Y222 together in phospho-enriched samples from cell cultures, the best transitions for the detection of T220 monophosphorylation were much weaker and show only a two fold increase in response to flg22 treatment as compared to a very strong increase for Y222 (10-15 fold) and T220/Y222 (20-25 fold) (see newly added Dataset EV4 with SRM data). It is known in animal and yeast systems that full activation of MAPKs requires phosphorylation on both T and Y residues (Sours et al., 2014) , while phosphorylation on the Y residue alone reduces the activity of MAPK by 3 orders of magnitude. On the other hand monophosphorylation on T alone does not result in detectable MAPK activity and has to our knowledge not been described before in in vivo samples. A recent interesting article shows that ERK2 is sequentially phosphorylated on tyrosine followed by threonine (Sours et al., 2014) . Our data on MPK6 is consistent with this model. Furthermore, we developed additional SRM assays to include detection of mono-phosphorylated and doubly phosphorylated MPK3 peptides and did additional measurements (shown in the new Dataset EV 4). We were able to measure phosphorylation on Y198 and on T196/Y198 in phospho-enriched cell culture samples, but we did not detect phosphorylation on T196 only. We next tried to measure all different variants of MPK6 and MPK3 phospho-peptides in phospho-enriched mkkk7 extracts. However, we were not able to detect monophosphorylated peptides (T220 or Y222) for MPK6 but could succesfully measure the T220/Y222 doubly phosphorylated version by SRM. We were not able to detect any MPK3 phospho-peptides in mkkk7 seedling samples. While we tried our best to address the point made by referee 2 by setting up the requested SRM assays and measuring these in mkkk7 mutant background, we cannot comment on the changes in mono-phosphorylated T and Y peptides for MPK6 or MPK3 in mkkk7. We have adjusted the text on page 7 line 23 to 27 and page 9 line 21-24 to reflect this additional data. We also added discussion of our data in relation to Sours et al., 2014 on page 7 (line 27-28) and page 9 (line 1-3). We thank the referee for encouraging us to pursue this in more depth and it has resulted in a better understanding and discussion of our data
If the major MKKK7 function is a negative regulation of MPK6 phosphorylation in response to flg22, resulting in enhanced FRK1 induction and resistance in mkkk7 mutant, their observation becomes beyond correlation. This should be addressed by comparing WT, mkkk7, mpk6 and mkkk7 mpk6 for FRK1 induction and bacterial resistance.
Response to referee: While we agree with the referee that these kinds of experiments are interesting, they are in our opinion beyond the scope of the current manuscript, as also noted by the first handeling editor Dr Pariente. Fig 6 are important to show. Response to referee: We measured the bacterial resistance of mkkk7 in 4 separate biological replicates, all showing enhanced resistance. In two of these replicates we also included a complemented mkkk7 line (mkkk7 35S:MKKK7-GFP). The data as represented in Figure 6B , is one of these two replicate experiments. Data represented in Figure EV6 was measured 3 times with similar results, as is the norm in the field. While we agree that statistic analysis is required on these types of experiments, due to the nature of variation between individual biological replicate experiments, statistics are normally done within and not on combined experiments. Our representation of the data is in line with what is expected in the field and we hope that the additional clarification convinces the referee we did our best to meet the required standard. We have adjusted the text to reflect this more clearly on page 12, lines 3 and 8 to 14.
Enhanced bacterial resistance data of mkkk7 in Fig6D and susceptible data of MKKK7ox in FigS7 are important data sets for this manuscript. It is not clear how many independent experiments were performed. These should be repeated at least three times and combine those experiments for data presentation and statistical analysis to show reproducibility and reliability. In addition, I do not think disease symptom data in

Fig4A, Fig5A and FigS5: They should perform independent experiments and present all combined data with proper statistics. Fig4B and C: RT-PCR is not quantitative, so please perform qRT-PCR with independent experiments with proper statistics. In addition, MKKK7 effect on FRK1 is much more dramatic than WRKY29, so I think that FigS5 should be included in the main figure (Fig5).
Response to referee: We thank the referee for expressing his concern over the replication and statistics in Figures 4 and 5. As indicated in the legend of Figure 4 , we have repeated the experiments in Figure 4A , 6 times to ensure that our data were accurately reflecting changes in gene expression in protoplasts of mkkk7 as compared to Col-0. We consistently observed the differences reflected in Figure 4A in these 6 independent assays. Since we used the dual luciferase system, all data shown in Figure 4A and 5A was corrected for variations in transformation efficiency of the protoplasts. While this enhances the confidence that changes observed reflect changes in transcription, the actual values varied in our hands from experiment to experiment and precluded us from averaging the data over several replicates and performing statistical analysis. The data in Figure 4A is also corroborated by the newly acquired qRT-PCR data now shown in revised Figure  4B and 4C. These data, generated with RNA from leaf tissue also shows that WRKY29 and FRK1 are expressed to a much higher level in mkkk7. We have performed two independent replicate experiments, applied statistics and all observed changes between Col-0 and mkkk7 after flg22 treatment are statistically significant. We believe the data is supporting the conclusions we have drawn previously and have clearly indicated the number of independent biological replicas done in Figure 4A and 5A. We are showing the data in Figure EV5 , from a single replicate experiment, as it supports our finding in Figure 5A . This data cannot be shown as a main figure, or on its own without the data represented in Figure 5A . Because both referee 2 and 3 make the same suggestion we have converted Figure S5 into Figure EV5 , giving the figure a more prominent positioning in the manuscript. Response to referee While we agree with the referee that there are some minor loading differences showing in the blot in the old Figure S4 we do not agree that the blot shows evidence for accumulated MPK6 protein level in mkkk7. We understand that in the absence of a mpk6 mutant the referee may not have been certain which band represents MPK6. We have previously shown that the sharp dark band in the middle of the blot corresponds to the MPK6 protein (Menke et al 2004) . We have now indicated this band with an arrow in the new Appendix Figure S4B . In Appendix Figure  S4A we also provide a Western blot probed with both the MPK6 antibody as well as the p44/42 antibody, which recognizes phosphorylated MPKs. On the Western blot we have samples for Col-0, mpk3 and mpk6 from tissue, treated for the indicated time with 1 µM flg22. These results support the indicated band in Figure S4B corresponds to MPK6 and we have also indicated this band with an arrow. This shows that the much lighter bands above and below the MPK6 band in Figure S4B are unspecific cross reactivities that occur in polyclonal rabbit antibody preparations.
FigS4: The major bands in MPK6 immunoblotting seem to be non-specific bands (perhaps
(Minor comments) 1. The last sentences in Abstract and Introduction: MKKK7 acts in PAMP signaling through FLS2 interaction are overstatements since relevance of MKKK7 and FLS2 interaction to MKKK7 function is not addressed.
Response to referee We see the referee's point for the last sentence of the Introduction and we have modified the last sentence of the introduction to address this. We have changed 'demonstrates' to 'suggests' and 'interaction' with 'association'. We believe the Abstract does not suffer the same overstatement and left the last sentence as it is.
MKKK7 is also described as MAP3Ke1, so this should be introduced for the sake of readers.
Response to referee : We agree with the reviewer that it would be good to mention the other names used for MKKK7, and we have modified line 7 and 8 on page 5 accordingly.
Page 15 line 12: "Flg22-induced MPK3 and MPK6 activation is required..." MAPK activation is sufficient for induction of FRK1 but it is not known that MAPK activation is "required". Several pathways may contribute to gene induction. Shut down of FRK1 induction by effectors cannot exclude the possibility that those effectors target multiple signaling components.
Response to referee : The referee has a valid point and we thank the reviewer for bringing this to our attention. We have rephrased the sentence on page 15 to more accurately reflect this nuance.
4. Page6 line 10: As far as I see, reciprocal co-IPs were not performed. Also, in Methods, "Pair wise" co-IPs does not seem to be appropriate. Response to referee: We disagree with the reviewer on this first point as we have done co-IPs using anti-GFP beads to IP FLS2-GFP and co-IP native MKKK7 as well as used MKKK7-YFP IPs to co-IP native FLS2. The referee is correct to note that we mistakenly wrote "Pair wise" co-IP. We have removed pair wise from line 19 on page 21.
Referee #3:
In general the conclusions are well-supported by the data. The only area of concern I have is with Figures 6E, 6F Figure  S6 , however, overexpression of MKKK7 causes similar symptoms in the absence of P. syringae. It is thus unclear from Figure 6 whether the observed symptoms are due to MKKK7 overexpression alone, or from infection with P. syringae. Figure 7G also Response to referee: We thank the referee for the kind review of our manuscript and the suggestions made to improve our manuscript. We now realize that in the submitted version of the manuscript Figure S6 has caused confusion and raised questions. While it is correct to note that overexpression of MKKK7 causes a spectrum of phenotypes when 35S:MKKK7-GFP is transformed in Col-0 background, we did not see any phenotype when the same construct was transformed in the mkkk7 mutant background. In addition we have checked MKKK7 expression levels in these transgenic lines by qRT-PCR and found that overexpression in Col-0 results in a 200 fold higher expression level of MKKK7, while overexpression in mkkk7 background gave a 50 fold higher expression level as compared to endogenous MKKK7 expression. Since the severe phenotype in Col-0 35S:MKKK7-GFP coincided with higher expression levels, we did not use these lines for any of our experiments and used the mkkk7 35S:MKKK7-GFP line for complementation of the enhanced resistance phenotype shown in Figure 6B . Based on this we also made the decision that the next generation of transgenic lines, overexpressing MKKK7 AA -and MKKK7 DD -GFP fusions, would be made using inducible XVE promotors in both the mkkk7 and Col-0 background. After screening the new transgenic lines, we took the inducible constructs in the Col-0 background forward, as they did not show any stressed phenotype after estradiol application and showed expression of the GFP construct after induction. We have added pictures of mature mkkk7 35S:MKKK7-GFP to Appendix Figure S4A to show the difference in phenotype between transgenic lines in different backgrounds. We also added pictures in Appendix Figure S4B of the lines used for the infection assays, one week prior to infection. None of these plants showed a growth or stressed phenotype before the infection. We modified the text on page 12, lines line 9 -14 and line 25 to more clearly describe the differences between the lines. We did not further investigate the phenotype of the Col-0 35S:MKKK7-GFP lines as these lines in many cases died from spontaneous infection before setting seeds.
and 7G. These images show symptoms on Arabidopsis plants infected with Pseudomonas syringae, including transgenic plants overexpressing MKKK7. As shown in
Other more minor suggestions for improvement:
1)Pg 1, Line 24: the word "we" should be inserted in front of "show" Response to referee : we thank the referee for pointing out this textual error and we have corrected it 2) Pg 5, Line 7: Should state in this sentence that MKKK7 belongs to the MEKK subfamily Response to referee : we thank the referee for bringing this to our attention. We have clarified the statement on page 5 accordingly 3) Pg 11, Line 11: Data shown in Figure S5 should be moved to Figure 5 . Response to referee : For the reasons explained in response to comment 4 from referee 2, we can not move Figure S5 to Figure 5. Response to referee : we thank the referee for bringing this to our attention and we concur that the suggestion made by the referee improves our manuscript. We have rephrased the lines on page 13 as suggested.
4) Pg
5) Pg 17, line 10: The statement that BIK1 and PBL1 are not required for flg22-induced MAPK activation needs a citation.
Response to referee : we thank the referee for bringing this to our attention and we have now added the reference (Ranf et al., 2014 BMC Plant Biol ) 2nd Editorial Decision 06 November 2015
Thank you for the submission of your revised manuscript to EMBO reports. We have now received the full set of referee reports that is copied below. As you will see, both referees are very positive about the study and request only changes to the text and the discussion and the replacement of the blot shown in Fig. S3B .
From the editorial side, there are also a few things that we need before we can proceed with the official acceptance of your study.
-You have mentioned in your previous correspondence that you and your collaborator are willing to share the entire proteomics data set. As this was one major request from referee #1 and I think it would enhance the impact of the study, please submit the proteomics data set with the revised version, possibly in an appropriate public database. In the case of mass spectrometry datasets, they should be deposited in a machine-readable format (e.g. mzML if possible) in one of the major public database, for example Pride (http://www.ebi.ac.uk/pride/) or PeptideAtlas(http://www.peptideatlas.org) and authors should follow the MIAPE recommendations (http://www.psidev.info/index.php?q=node/91).
-The Datasets EV2, EV3 and EV4 all seem rather to be figures than datasets. They should be part of the EV figures (or the Appendix). We can accommodate up to 5 or even 6 EV figures.
-The Dataset EV5 seems to be a mixture of three figures showing a list of primers and constructs used as well as a transition list of phosphopeptides analyzed by SRM. Was this intended? The primer and construct list could be incorporated into the Materials and Methods or alternatively in the Appendix and the phosphopeptides can constitute a Dataset.
-In general for Datasets EV1 and EV5 the deposition in the format of an excel file would be preferred.
-Currently the legends for the Appendix figures are part of the main manuscript. Please move them to the Appendix file. The Appendix has to be provided in a single PDF and should contain a short table of contents as well as the figure legends.
-Please reformat the references to match the EMBO reports style (numbered). Please contact me in case you need the corresponding EndNote file.
-As a standard procedure, we edit the title and abstract of manuscripts to make them more accessible to a general readership. Please find the edited version below my signature and let me know if you do NOT agree with any of the changes.
-Every EMBO reports paper now includes a 'Synopsis' to further enhance its discoverability. Synopses are displayed on the html version and they are freely accessible to all readers. The synopsis includes a short standfirst as well as 2-4 one sentence bullet points that summarize the paper. These should be complementary to the abstract -i.e. not repeat the same text. This is a good place to be more informative and include, as appropriate, key acronyms and quantitative and organism (yeast, mammalian cells, etc) information. Could you supply the synopsis, bullet points and the synopsis image (500 x 400 pixel)?
We look forward to seeing a final version of your manuscript as soon as possible.
REFEREE REPORTS
Referee #2:
The authors have adequately addressed most points, and this reviewer appreciates their efforts on additional SRM measurements to quantify phosphorylation of MPK3 and MPK6 at the TEY motif. Although there is space for improvement in statistical analysis, this manuscript has been improved.
(Recommendations for further improvements) 1. P12 line 21 "However, overexpressing...": I would recommend rephrasing this sentence as it is difficult to assess without pathogen growth measurement if a plant is more susceptible at an earlier stage.
2. Figure S3B : I would still recommend showing a better blot (higher resolution or including mpk6 mutants as shown in 3SA) since it would strengthen the claim that there is no difference in MPK6 protein levels between Col and mapkkk7.
3. Discussion: It would be useful to discuss the power of SRM measurements with synthetic phopshopeptides since this could be widely applicable to other researches.
Referee #3:
The authors have done a nice job of addressing my previous criticisms and I have no additional suggestions for improvement. This manuscript makes a very nice contribution to our understanding of PAMP signaling in plants.
2nd Revision -authors' response 27 November 2015
We have now revised the manuscript and addressed all comments and suggestions made by you and reviewer #2. Below I outline the changes to the manuscript and figures Figure EV3 while dataset EV4 is now Figure EV4 . Dataset EV3 does contain graphs but since it also contains all the data exported from Skyline as well as the calculations and statistics Dataset EV2 has remained a Dataset and is now relabeled dataset EV2. As requested this Dataset EV2 is in Excel file format. We have added the transition list for SRM (that was initially part of dataset EV5) to the new Dataset EV2. The current mauncript has only two EV datasets; Dataset EV1 contains the FLS2 Co-IP data and Dataset EV2 contains all the SRM data. Tables I to III and Appendix figures 1 to 3 and corresponding figure legends. One Appendix figure has been moved to the EV figures and has become the revised Figure EV2 . We have written a Synopsis in the format you have suggested and prepared a synopsis Image with the 500 x 400 pixel dimension. The synopsis was added to the manuscript text after the Abstract and the Synopsis Image was uploaded as a separate image file
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